Orgotein efficacy in ameliorating side effects due to radiation therapy.
D000595:Amino Acid Sequence; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects*; D013482:Superoxide Dismutase / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy
D000893:Anti-Inflammatory Agents; D008667:Metalloproteins; D013482:Superoxide Dismutase; C005180:orgotein